- Home
- LBRX vs VLGEA Comparison
LBRX vs VLGEA Comparison
Compare LBRX & VLGEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LBRX | VLGEA |
|---|---|---|
| Founded | 2015 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 563.2M | 503.4M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | LBRX | VLGEA |
|---|---|---|
| Price | $22.65 | $34.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $49.00 | N/A |
| AVG Volume (30 Days) | ★ 239.5K | 41.3K |
| Earning Date | 02-15-2026 | 03-03-2026 |
| Dividend Yield | N/A | ★ 2.87% |
| EPS Growth | N/A | ★ 7.88 |
| EPS | N/A | ★ 3.75 |
| Revenue | N/A | ★ $2,345,586,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.28 |
| Revenue Growth | N/A | ★ 3.88 |
| 52 Week Low | $13.36 | $30.08 |
| 52 Week High | $24.46 | $40.15 |
Technical Indicators
Market Signals| Indicator | LBRX | VLGEA |
|---|---|---|
| Relative Strength Index (RSI) | 52.48 | 39.03 |
| Support Level | $21.82 | $34.84 |
| Resistance Level | $24.46 | $35.78 |
| Average True Range (ATR) | 1.84 | 0.88 |
| MACD | 0.08 | -0.05 |
| Stochastic Oscillator | 53.25 | 18.01 |
Price Performance
Historical ComparisonAbout LBRX LB Pharmaceuticals Inc
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.